Literature DB >> 8146175

Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.

C Y Chen1, J D Oliner, Q Zhan, A J Fornace, B Vogelstein, M B Kastan.   

Abstract

Normal p53 function is required for optimal arrest of cells in the G1 phase of the cell cycle following certain types of DNA damage. Loss of this cell cycle checkpoint may contribute to tumor development by increasing the number of genetic abnormalities in daughter cells following DNA damage. The MDM2 protein is an endogenous gene product that binds to the p53 protein and is able to block p53-mediated transactivation of cotransfected reporter constructs; thus, interactions between MDM2 and p53 in this checkpoint pathway following ionizing irradiation were examined. Though increases in p53 protein by DNA damage were not abrogated by MDM2 overexpression, increased levels of MDM2, resulting either from endogenous gene amplification or from transfection of an exogenous expression vector, were associated with a reduction in the ability of cells to arrest in G1 following irradiation. In addition, expression of endogenous MDM2 was enhanced by ionizing irradiation at the level of transcription in a p53-dependent fashion. These observations demonstrate that MDM2 overexpression can inhibit p53 function in a known physiologic pathway and are consistent with the hypothesis that MDM2 may function in a "feedback loop" mechanism with p53, possibly acting to limit the length or severity of the p53-mediated arrest following DNA damage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8146175      PMCID: PMC43434          DOI: 10.1073/pnas.91.7.2684

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

3.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

4.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

Authors:  Y Yin; M A Tainsky; F Z Bischoff; L C Strong; G M Wahl
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

5.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

6.  Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.

Authors:  T Crook; J A Tidy; K H Vousden
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

7.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

9.  The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.

Authors:  C A Finlay
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  59 in total

Review 1.  The complexity of radiation stress responses: analysis by informatics and functional genomics approaches.

Authors:  A J Fornace; S A Amundson; M Bittner; T G Myers; P Meltzer; J N Weinsten; J Trent
Journal:  Gene Expr       Date:  1999

Review 2.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

Review 3.  Mdm2: the ups and downs.

Authors:  T Juven-Gershon; M Oren
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

4.  A repertoire of cell cycle regulators whose expression is coordinated with human cytotrophoblast differentiation.

Authors:  O Genbacev; M T McMaster; S J Fisher
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

5.  Hydrogen peroxide-induced apoptosis in human hepatoma cells is mediated by CD95(APO-1/Fas) receptor/ligand system and may involve activation of wild-type p53.

Authors:  C Huang; J Li; R Zheng; K Cui
Journal:  Mol Biol Rep       Date:  2000-03       Impact factor: 2.316

6.  Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function.

Authors:  L R Bonin; J K McDougall
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

7.  The Mdm2 oncoprotein interacts with the cell fate regulator Numb.

Authors:  T Juven-Gershon; O Shifman; T Unger; A Elkeles; Y Haupt; M Oren
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

Review 8.  The regulation of the p53-mediated stress response by MDM2 and MDM4.

Authors:  Mary Ellen Perry
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-01       Impact factor: 10.005

9.  QM-FISH analysis of the genes involved in the G1/S checkpoint signaling pathway in triple-negative breast cancer.

Authors:  Sheng Zhang; Yingbo Shao; Guofang Hou; Jingchao Bai; Weiping Yuan; Linping Hu; Tao Cheng; Anders Zetterberg; Jin Zhang
Journal:  Tumour Biol       Date:  2013-10-05

Review 10.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.